These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents. Pfaller MA, Wey S, Gerarden T, Houston A, Wenzel RP. Diagn Microbiol Infect Dis; 1989; 12(1):1-4. PubMed ID: 2714066 [Abstract] [Full Text] [Related]
5. Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents. Pfaller M, Gordee R, Gerarden T, Yu M, Wenzel R. Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):564-7. PubMed ID: 2504601 [Abstract] [Full Text] [Related]
6. Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Pfaller MA, Gerarden T, Yu M, Wenzel RP. Diagn Microbiol Infect Dis; 1988 Sep; 11(1):1-9. PubMed ID: 3219817 [Abstract] [Full Text] [Related]
7. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species. Smith KR, Lank KM, Dismukes WE, Cobbs CG. Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435 [Abstract] [Full Text] [Related]
10. Activity of cilofungin (LY121019) against Candida species in vitro. Odds FC. J Antimicrob Chemother; 1988 Dec; 22(6):891-7. PubMed ID: 3243737 [Abstract] [Full Text] [Related]
12. In vitro and in vivo anti-Candida activity and toxicology of LY121019. Gordee RS, Zeckner DJ, Ellis LF, Thakkar AL, Howard LC. J Antibiot (Tokyo); 1984 Sep; 37(9):1054-65. PubMed ID: 6389460 [Abstract] [Full Text] [Related]
13. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C, Yamane N, Nakasone I, Onaga S, Nakamura K. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005 Sep; 16(2):127-33. PubMed ID: 16536058 [Abstract] [Full Text] [Related]
14. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y. Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100 [Abstract] [Full Text] [Related]
17. In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes. Van der Auwera P, Meunier F. J Antimicrob Chemother; 1989 Nov; 24(5):747-63. PubMed ID: 2557318 [Abstract] [Full Text] [Related]
19. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species. Valentín A, Cantón E, Pemán J, Fernandez-Rivero ME, Tormo-Mas MA, Martínez JP. J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657 [Abstract] [Full Text] [Related]